Orexo Us Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OREXO US INC, and when can generic versions of OREXO US INC drugs launch?
OREXO US INC has one approved drug.
There are ten US patents protecting OREXO US INC drugs.
There are forty-seven patent family members on OREXO US INC drugs in thirty-one countries.
Summary for Orexo Us Inc
| International Patents: | 47 |
| US Patents: | 10 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Orexo Us Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orexo Us Inc | ZUBSOLV | buprenorphine hydrochloride; naloxone hydrochloride | TABLET;SUBLINGUAL | 204242-001 | Jul 3, 2013 | RX | Yes | No | 11,433,066 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Orexo Us Inc | ZUBSOLV | buprenorphine hydrochloride; naloxone hydrochloride | TABLET;SUBLINGUAL | 204242-003 | Dec 11, 2014 | RX | Yes | No | 8,940,330 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Orexo Us Inc | ZUBSOLV | buprenorphine hydrochloride; naloxone hydrochloride | TABLET;SUBLINGUAL | 204242-003 | Dec 11, 2014 | RX | Yes | No | 10,946,010 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Orexo Us Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Orexo Us Inc | ZUBSOLV | buprenorphine hydrochloride; naloxone hydrochloride | TABLET;SUBLINGUAL | 204242-005 | Jun 4, 2015 | 8,454,996 | ⤷ Sign Up |
| Orexo Us Inc | ZUBSOLV | buprenorphine hydrochloride; naloxone hydrochloride | TABLET;SUBLINGUAL | 204242-006 | Oct 4, 2016 | 8,454,996 | ⤷ Sign Up |
| Orexo Us Inc | ZUBSOLV | buprenorphine hydrochloride; naloxone hydrochloride | TABLET;SUBLINGUAL | 204242-002 | Jul 3, 2013 | 8,454,996 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for OREXO US INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Sublingual Tablets | 8.6 mg/2.1 mg and 11.4 mg/2.9 mg | ➤ Subscribe | 2015-07-24 |
| ➤ Subscribe | Sublingual tablets | 0.7 mg/0.18 mg | ➤ Subscribe | 2017-05-03 |
| ➤ Subscribe | Sublingual Tablets | 1.4 mg/0.36 mg and 5.7 mg/1.4 mg | ➤ Subscribe | 2013-10-22 |
| ➤ Subscribe | Sublingual Tablets | 2.9 mg/7.1 mg | ➤ Subscribe | 2015-12-21 |
International Patents for Orexo Us Inc Drugs
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
